| |
| |
|
| Insider
Information: |
Szostak M Anne |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
93,953 |
|
|
Indirect Shares
|
32,062 |
|
|
| Direct
Value |
$266,027 |
|
|
|
Indirect Value
|
$3,892,688 |
|
|
| Total
Shares |
126,015 |
|
|
| Total
Value |
$4,158,715 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 170.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tupperware Corp |
TUP |
Director |
2022-05-06 |
88,858 |
2016-05-24 |
7,261 |
Premium* |
|
|
Belo Corp A |
BLC |
Director |
2013-12-23 |
0 |
2013-12-23 |
0 |
Premium* |
|
|
SFN Group Inc |
SFN |
Director |
2011-09-02 |
0 |
2005-06-09 |
0 |
Premium* |
|
|
Keurig Dr Pepper Inc |
KDP |
Director |
2018-07-09 |
5,095 |
2018-03-02 |
18,240 |
Premium* |
|
|
Idexx Laboratories Inc |
IDXX |
Director |
2024-05-08 |
0 |
2024-05-08 |
6,561 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2019-08-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,283 |
8,699 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2019-08-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
7,783 |
6,199 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2019-11-04 |
4 |
S |
$279.10 |
$917,162 |
I/I |
(3,283) |
2,916 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-02-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,790 |
11,796 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,790 |
584 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-02-18 |
4 |
OE |
$43.68 |
$383,947 |
D/D |
8,790 |
9,734 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-02-18 |
4 |
S |
$286.18 |
$2,516,469 |
I/I |
(8,790) |
2,916 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
17,518 |
10,217 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
16,934 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
584 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-29 |
4 |
S |
$306.12 |
$2,369,921 |
I/I |
(7,722) |
0 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,722 |
7,722 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,722 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-29 |
4 |
OE |
$63.95 |
$493,822 |
D/D |
7,722 |
7,722 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-04 |
4 |
S |
$488.24 |
$5,815,816 |
I/I |
(11,876) |
0 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,876 |
11,876 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,876 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-04 |
4 |
OE |
$64.69 |
$888,128 |
D/D |
11,876 |
11,876 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,217 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,217 |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,434 |
10,217 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-08-06 |
4 |
S |
$681.49 |
$2,063,616 |
I/I |
(3,000) |
7,217 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
660 |
6,557 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-02-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
660 |
660 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
224 |
224 |
0 |
- |
|
155 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
